Streptococcus agalactiae Meningitis Treatment
For neonates with Group B Streptococcus (GBS) meningitis, treat with ampicillin 50 mg/kg IV every 6 hours (age 1-4 weeks) or every 8 hours (age <1 week) plus gentamicin 2.5 mg/kg IV every 8 hours (age 1-4 weeks) or every 12 hours (age <1 week) for 14-21 days. For adults, empiric therapy with ceftriaxone 2g IV every 12 hours or cefotaxime 2g IV every 6 hours is appropriate, with treatment duration of 14-21 days 1, 2.
Treatment Approach by Age Group
Neonates (<1 month)
Empiric therapy (before organism identification):
- Age <1 week: Ampicillin 50 mg/kg IV every 8 hours PLUS cefotaxime 50 mg/kg IV every 8 hours OR gentamicin 2.5 mg/kg IV every 12 hours 2
- Age 1-4 weeks: Ampicillin 50 mg/kg IV every 6 hours PLUS cefotaxime 50 mg/kg IV every 6-8 hours OR gentamicin 2.5 mg/kg IV every 8 hours 2
Definitive therapy (once GBS confirmed):
- Continue ampicillin-based regimen
- Duration: 14-21 days (minimum 2 weeks beyond first sterile CSF culture or 3 weeks total, whichever is longer) 1
The combination of a penicillin (ampicillin) with an aminoglycoside or cefotaxime provides synergistic bactericidal activity against GBS and covers the most common neonatal pathogens 3, 4.
Adults
Empiric therapy (age-dependent):
- Age <50 years: Ceftriaxone 2g IV every 12 hours OR cefotaxime 2g IV every 4-6 hours 2
- Age ≥50 years: Add ampicillin 2g IV every 4 hours to cover Listeria monocytogenes 2
Definitive therapy (once GBS confirmed):
- Continue ceftriaxone 2g IV every 12 hours OR cefotaxime 2g IV every 6 hours
- Can narrow to ampicillin 2g IV every 4 hours if susceptible 2
- Duration: 14-21 days 1
Critical Treatment Considerations
Timing is Essential
Antibiotic therapy must be initiated within 1 hour of hospital presentation 2. Delayed treatment is strongly associated with death and poor outcomes. If lumbar puncture is delayed (e.g., for CT imaging), start empiric antibiotics immediately on clinical suspicion—do not wait for CSF results 2.
Antimicrobial Resistance Patterns
While GBS remains highly susceptible to β-lactam antibiotics, emerging resistance requires awareness:
- Penicillin/ampicillin: Resistance remains rare but has been documented, particularly in Japan 5, 6. MICs of 0.25-0.5 μg/mL have been reported 5, 6
- Macrolides/clindamycin: Substantial global resistance limits their use as alternatives 7
- Cephalosporins: Generally retain activity, though borderline susceptibility has been observed 6
- Vancomycin: Remains fully active and should be considered for severe β-lactam allergy 7
When Standard Therapy May Be Insufficient
If the patient is not responding to standard therapy after 48-72 hours:
- Repeat lumbar puncture to assess CSF sterilization
- Consider adding vancomycin 15-20 mg/kg IV every 12 hours (target trough 15-20 μg/mL) if resistance suspected 8
- Obtain susceptibility testing to guide therapy
- Consult infectious disease specialists
Special Populations
Immunocompromised adults (diabetes, cancer, immunosuppressive therapy):
- GBS meningitis is more common in this population 9, 10
- Use standard adult dosing but maintain high index of suspicion
- Consider longer treatment duration (21 days) if slow to respond
- Monitor closely for complications
Patients with penicillin allergy:
- Severe allergy: Vancomycin 15-20 mg/kg IV every 12 hours (target trough 15-20 μg/mL) 7
- Non-severe allergy: Cephalosporins (ceftriaxone/cefotaxime) are generally safe
- Avoid macrolides due to high resistance rates 7
Duration of Therapy
The evidence-based durations are:
- Neonates: 14-21 days (minimum 2 weeks beyond first sterile CSF or 3 weeks total, whichever is longer) 1
- Adults: 14-21 days 1
Do not shorten therapy even if clinical improvement occurs earlier. One small study suggested 6 days may be sufficient for neonatal GBS infection 11, but this included primarily sepsis cases without confirmed meningitis and had a very small sample size—this is insufficient evidence to recommend shorter courses for meningitis.
Common Pitfalls to Avoid
- Delaying antibiotics for diagnostic procedures: Start treatment immediately; do not wait for LP or imaging 2
- Assuming all GBS is penicillin-susceptible: While rare, resistance exists—obtain cultures and susceptibilities 5, 6
- Using macrolides as alternatives: High resistance rates make erythromycin and clindamycin unreliable 7
- Stopping therapy too early: Complete the full 14-21 day course regardless of clinical improvement 1
- Missing GBS in adults: Consider GBS in immunocompromised adults with meningitis, not just neonates 9, 10